BioCentury
ARTICLE | Company News

genOway, StemCells deal

March 26, 2012 7:00 AM UTC

genOway received exclusive, worldwide rights to StemCells' Internal Ribosome Entry Site (IRES) technology to develop and commercialize genetically engineered mice. The technology genetically modifies ...